Where is the evidence for effectiveness of treatments for the menopause? Introducing the Cochrane Collaboration

Climacteric

Volumn 1, Issue 1, 1998, Pages 5-11

  Farquhar, C M ^a   MacLennan, A H ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Cochrane collaboration; Hormone replacement therapy; Menopause; Randomized controlled trials; Systematic reviews

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; INTERNATIONAL COOPERATION; LIBRARY; MENOPAUSE; ORGANIZATION; RANDOMIZED CONTROLLED TRIAL; REGISTER; RESEARCH;

EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; INTERNATIONAL COOPERATION; LIBRARIES, MEDICAL; MENOPAUSE; ORGANIZATIONS; RANDOMIZED CONTROLLED TRIALS; REGISTRIES; RESEARCH;

EID: 0032023874     PISSN: 13697137     EISSN: None     Source Type: Journal    
DOI: 10.3109/13697139809080675     Document Type: Article

References (18)

1. Davidoff F, Haynes B, Sackett D, Smith R. Evidence based medicine: a new journal to help doctors identify the information they need. Br Med J 1995;310:1085-6
2. Sackett DL. Surveys of self reported reading times of consultants in Oxford, Birmingham, Milton-Keynes, Bristol, Leicester and Glasgow. In Sackett DL, Richardson WS, Rosenberg WMC, Haynes RB, eds. Evidence Based Medicine. London: Churchill Livingstone, 1996:8-9
3. Antman E, Lau J, Kupelnick B, Mosteller F, Chalmers TC. A comparison of results of meta-analyses of randomized controlled trials and recommendations of clinical experts. Treatments for myocardial infarction. J Am Med Assoc 1992; 268:240-8
4. Cochrane AL. 1931-1971: a critical review, with particular reference to the medical profession. In Teeling Smith G, ed. Medicines for the Year 2000. London: Office of Health Economics, 1979:1-11
5. Cochrane AL. Effectiveness and Efficiency, 1972. Random Reflections on Health Services. London: The Nuffield Provincial Hospitals Trust, 1972
6. Cochrane A. Foreword. In Chalmers I, Inkin MW, Keirse MJNC, eds. Effective Care in Pregnancy and Childbirth. Oxford: Oxford University Press, 1989
7. Grodstein F, Stampfer MJ, Manson JE, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996;335:453-61
8. Nachtigall LE, Nachtigall RH, Nachtigall RD, Beckman EM. Estrogen replacement therapy. I. A 10 year prospective study in the relationship to carcinoma and cardiovascular and metabolic problems. Obstet Gynecol 1997;54:74-94
9. Johnson S. Current prospective randomized trials; Women's Health Initiative study in menopause messages. Video highlights of the 8th International Congress on the Menopause. Foundation studies, Women's and Children's Hospital, North Adelaide, Australia, 1997
10. Samsioe G. The menopause revisited. Int J Gynaecol Obstet 1995;51:1-13
11. Hemminski E, McPherson K. Impact of postmenopausal hormone therapy on cardiovascular events and cancer: pooled data from clinical trials. Br Med J 1997;315:149-53
12. Henry DA, Robertson J, Gillespie WG, O'Connell D, Cumming R. Meta-analysis on Interventions for Prevention and Treatment of Post Menopausal Osteoporosis and Fracture. Report to the Australian Institute of Health and Welfare, and Commonwealth Department of Health and Family Services, 1995
13. Rozenberg S, Kroll M, Vandromme J. Decision factors influencing hormone replacement therapy. Br J Obstet Gynaecol 1996;103(Suppl 13):92-8
14. Chalmers I, Dickersin K, Chalmers TC. Getting to grips with Archie Cochrane's agenda. Br Med J 1992;305:786-8
15. Oxman AD. Checklist for review articles. Br Med J 1994;309:648-51
16. Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. Br Med J 1994;309:1286-91
17. Vandekerckhove P, O'Donovan PA, Lilford RJ, Harada TW. Infertility treatment: from cookery to science. The epidemiology of randomized controlled trials. Br J Obstet Gynaecol 1993;100: 1005-36
18. Naylor CD. Grey zones of clinical practice: some limits to evidence based medicine. Lancet 1995; 345:840-2